Lessons From a Multisite International Trial in the Caribbean and South America of an HIV-1 Canarypox Vaccine (ALVAC-HIV vCP1452) With or Without Boosting With MN rgp120
Year: 2007
Type: article
Study design: Clinical Trial
Authors: Farley Cleghorn, Jean W Pape, Mauro Schechter, Courtenay Bartholomew, Jorge Sanchez, Noreen Jack, Barbara J Metch, Marianne Hansen, Mary Allen, Huyen Cao, David C Montefiori, Georgia D Tomaras, Sanjay Gurunathan, Donna J Eastman, Regina F do Lago, Sonic Jean, Javier R Lama, Dale N Lawrence, Peter F Wright
Institutions: California Health and Human Services Agency, Duke Medical Center, Gheskio Centers, Universidade Federal do Rio de Janeiro, Sanofi (United States), University of Maryland, Baltimore, Asociación Civil Impacta Salud y Educación, Vanderbilt University Medical Center, Fred Hutch Cancer Center, National Institutes of Health, National Institute of Allergy and Infectious Diseases
Language: English
Topic: HIV Research and Treatment
Subfield: Virology
Field: Immunology and Microbiology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W1991253838